AXIS Capital (AXS) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
1 Jul, 2026Executive summary
Achieved Q2 2025 net income of $216 million ($2.72 per diluted share) and operating income of $261 million ($3.29 per diluted share), both up year-over-year, with annualized operating ROE of 19% and record diluted book value per share of $70.34, up 18.6% year-over-year.
Gross premiums written reached $2.5 billion, up 3.1% year-over-year, with $732 million in new business.
Insurance segment set records in premium volume ($1.9 billion) and underwriting income ($152 million) with an 85.3% combined ratio.
Completed a $2 billion loss portfolio transfer reinsurance agreement to retrocede reserves to Enstar.
Book value per diluted share rose 5.8% sequentially and 18.6% year-over-year to $70.34.
Financial highlights
Net income available to common shareholders was $216 million ($2.72 per diluted share); operating income was $261 million ($3.29 per diluted share).
Combined ratio improved to 88.9%, reflecting strong underwriting and disciplined risk management.
Net investment income for Q2 was $187 million, with a $16.3 billion investment portfolio.
Debt to total capital ratio at 17.6%, supporting a strong balance sheet.
Book value per diluted share increased 18.6% to $70.34 over the past 12 months.
Outlook and guidance
Management remains focused on profitable growth, operational enhancements, and technology investments.
Insurance premium growth in the second half of 2025 anticipated to exceed the 6% seen in the first half.
Reinsurance premium growth expected to be flat to low single digits for the full year.
Investment income outlook remains favorable, with market yields above book yield.
Ongoing uncertainty from trade and geopolitical factors is being actively managed through underwriting practices.
Latest events from AXIS Capital
- Record Q2 net income, operating EPS, and capital returns highlight strong specialty growth.AXS
Q2 20241 Jul 2026 - Net income rose 33% to $247M, with 11% premium growth and strong capital returns.AXS
Q1 20261 May 2026 - Specialty growth, performance-based pay, strong governance, and ESG leadership highlighted.AXS
Proxy filing1 May 2026 - Record financial performance, strong governance, and robust pay-for-performance alignment highlighted.AXS
Proxy filing2 Apr 2026 - Director elections, executive pay, and auditor appointment headline the 2026 annual meeting.AXS
Proxy filing2 Apr 2026 - Record premiums, 18.3% book value growth, and improved combined ratio marked the year.AXS
Q4 20253 Feb 2026 - Q3 net income was $173M, with record investment income and strong specialty growth.AXS
Q3 202417 Jan 2026 - LPT with Enstar shifts $2.35B in reserves, boosting specialty focus and capital flexibility.AXS
UBS Global Specialty Insurance/Reinsurance Virtual Conference 202411 Jan 2026 - Record 2024 earnings, premium growth, and capital returns with improved profitability.AXS
Q4 20249 Jan 2026